Bridgebio Oncology Therapeutics, Inc. (BBOT)
1.815
-0.04
(-2.42%)
USD |
NASDAQ |
Nov 20, 16:00
1.815
0.00 (0.00%)
After-Hours: 20:00
Bridgebio Oncology Therapeutics Gross Profit (TTM) : -0.763M for Sept. 30, 2026
Gross Profit (TTM) Chart
Historical Gross Profit (TTM) Data
| Date | Value |
|---|---|
| September 30, 2026 | -0.763M |
| June 30, 2026 | -0.987M |
| March 31, 2026 | -0.977M |
| December 31, 2025 | -0.845M |
| September 30, 2025 | -0.703M |
| June 30, 2025 | -0.443M |
| March 31, 2025 | -0.262M |
| Date | Value |
|---|---|
| December 31, 2024 | -0.208M |
| September 30, 2024 | -0.156M |
| June 30, 2024 | 0.00 |
| March 31, 2024 | 0.00 |
| December 31, 2023 | 0.00 |
| December 31, 2022 | 0.00 |
Gross Profit Definition
Annual, Interim and Preliminary Items - Commercial, Other Financial Companies
Gross Profit (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Gross Profit (TTM) Benchmarks
| Korsana Biosciences, Inc. | -0.033M |
| IRulya Therapeutics, Inc. | -0.131M |
| PepGen Inc. | -1.155M |
| Q32 Bio, Inc. | 53.39M |
| Oncolytics Biotech, Inc. | -0.048M |